Showing results (131-140 of 253) with videos related to
Sort By:
Pageof 26
Blood|February 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.Transplantation and Cellular Therapy|September 10, 2025
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 TrialsAndrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, et al.Blood Advances|October 19, 2021
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapyKrishna R Juluri, Qian Vicky Wu, Jenna Voutsinas, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2019
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T CellsAna Cordeiro, Evandro D Bezerra, Alexandre V Hirayama, et al.The Journal of Clinical Investigation|June 9, 2015
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell graftsMarie Bleakley, Shelly Heimfeld, Keith R Loeb, et al.Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantationAbraham Guerrero, Stanley R Riddell, Jan Storek, et al.Blood|October 24, 2002
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityMichael Boeckh, Wendy Leisenring, Stanley R Riddell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigensScott S Tykodi, Edus H Warren, John A Thompson, et al.Cancer Research|November 12, 2009
Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cellsChristine E Brown, Renate Starr, Catalina Martinez, et al.Pageof 26